| |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 12/24 | Mar 11/24 | Verrico, Christopher | Direct Ownership | Common Shares | 10 - Acquisition in the public market | 16,000 | |
Feb 22/24 | Feb 19/24 | Verrico, Howard Jarman | Direct Ownership | Common Shares | 16 - Acquisition under a prospectus exemption | 450,000 | |
Oct 24/23 | Oct 20/23 | Verrico, Howard Jarman | Direct Ownership | Common Shares | 97 - Other | 444,444 | |
Sign up or login above to see all SEDI filings within the past 6 months. |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 12/24 | Mar 11/24 | Verrico, Christopher | Direct Ownership | Common Shares | 10 - Acquisition in the public market | 16,000 | |
Feb 22/24 | Feb 19/24 | Verrico, Howard Jarman | Direct Ownership | Common Shares | 16 - Acquisition under a prospectus exemption | 450,000 | |
Oct 24/23 | Oct 20/23 | Verrico, Howard Jarman | Direct Ownership | Common Shares | 97 - Other | 444,444 | |
Sign up or login above to see all SEDI filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. |
Competitors with Recent Insider Filings |
ESSA Pharma (V:EPI*CA) |
Zentek (V:ZEN*CA) |
Microbix Biosystems (T:MBX*CA) |